These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34177931)

  • 1. Large-Scale Imputation of KIR Copy Number and HLA Alleles in North American and European Psoriasis Case-Control Cohorts Reveals Association of Inhibitory KIR2DL2 With Psoriasis.
    Ahn R; Vukcevic D; Motyer A; Nititham J; Squire DM; Hollenbach JA; Norman PJ; Ellinghaus E; Nair RP; Tsoi LC; Oksenberg J; Foerster J; Lieb W; Weidinger S; Franke A; Elder JT; Jorgenson E; Leslie S; Liao W
    Front Immunol; 2021; 12():684326. PubMed ID: 34177931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.
    Pontikos N; Smyth DJ; Schuilenburg H; Howson JM; Walker NM; Burren OS; Guo H; Onengut-Gumuscu S; Chen WM; Concannon P; Rich SS; Jayaraman J; Jiang W; Traherne JA; Trowsdale J; Todd JA; Wallace C
    BMC Genomics; 2014 Apr; 15():274. PubMed ID: 24720548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.
    Hollenbach JA; Ladner MB; Saeteurn K; Taylor KD; Mei L; Haritunians T; McGovern DP; Erlich HA; Rotter JI; Trachtenberg EA
    Immunogenetics; 2009 Oct; 61(10):663-71. PubMed ID: 19789864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis.
    Chandran V; Bull SB; Pellett FJ; Ayearst R; Pollock RA; Gladman DD
    Rheumatology (Oxford); 2014 Feb; 53(2):233-9. PubMed ID: 24185760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased HLA-C1 alleles in couples of KIR2DL2 positive women with recurrent pregnancy loss.
    Yang X; Yang E; Wang WJ; He Q; Jubiz G; Katukurundage D; Dambaeva S; Beaman K; Kwak-Kim J
    J Reprod Immunol; 2020 Nov; 142():103186. PubMed ID: 32846355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
    Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
    Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation.
    Zuo W; Yu XX; Liu XF; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Zhao XS; Huang XJ; Zhao XY
    Front Immunol; 2022; 13():814334. PubMed ID: 35572602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of KIR/HLA Genotypes and Their Association with Psoriasis Vulgaris in the Western Mexican Population.
    Graciano-Machuca O; Alvarado-Navarro A; Ramírez-Dueñas MG; Villanueva-Quintero DG; Velarde-de la Cruz EE; Machado-Sulbarán AC; Montoya-Buelna M; Sánchez-Hernández PE
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32235781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
    Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
    Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
    Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
    J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
    Roberts CH; Molina S; Makalo P; Joof H; Harding-Esch EM; Burr SE; Mabey DC; Bailey RL; Burton MJ; Holland MJ
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2744. PubMed ID: 24651768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of KIR Genes and MHC Class I Ligands with Atopic Dermatitis.
    Margolis DJ; Mitra N; Hoffstad OJ; Kim BS; Monos DS; Phillips EJ
    J Immunol; 2021 Sep; 207(6):1522-1529. PubMed ID: 34408014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.
    Levinson RD; Du Z; Luo L; Monnet D; Tabary T; Brezin AP; Zhao L; Gjertson DW; Holland GN; Reed EF; Cohen JH; Rajalingam R
    Genes Immun; 2008 Apr; 9(3):249-58. PubMed ID: 18340360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
    Akhtari M; Farazmand A; Mahmoudi M; Akbarian M; Ahmadzadeh N; Mirkazemi Z; Mostafaei S; Jamshidi AR
    Lupus; 2016 Oct; 25(11):1244-53. PubMed ID: 26989167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.
    Martin MP; Nelson G; Lee JH; Pellett F; Gao X; Wade J; Wilson MJ; Trowsdale J; Gladman D; Carrington M
    J Immunol; 2002 Sep; 169(6):2818-22. PubMed ID: 12218090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.